NHI
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
National Health Investors, Inc.
- Nom
- National Health Investors, Inc.
- Secteur
- Real Estate
- Industrie
- REIT - Healthcare Facilities
- Bourse
- NYSE
- Capitalisation
- $3.3B
- Employés
- 32
- PDG
- D. Eric Mendelsohn
- Site web
- https://www.nhireit.com
- Marché
- ABRBNLCDPCWKEPRGRP-UN
Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse financing options, including sale-leaseback arrangements, joint ventures, and various debt instruments such as mortgage and mezzanine loans, targeting properties that cater to both essential care needs and discretionary services. NHI's broad holdings feature independent living, assisted living, and memory care facilities, as well as entrance-fee retirement communities, skilled nursing homes, medical office complexes, and specialized hospitals.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Decouvert par les declarations du Congres
- Insiders
- —
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- —
- Last synced
-
2026-10-06 10:56:08
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
No Form 4 filings for this company in this window.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2026-07-10 | Gilbert Cisneros | Buy | $1,001 - $15,000 | Filing |
| 2026-07-09 | Gilbert Cisneros | Buy | $1,001 - $15,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-07-10 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2026-01-15 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2022-09-01 | Virginia Ann Foxx | Sale (Full) | $50,001 - $100,000 |
| 2022-06-28 | Virginia Ann Foxx | Purchase | $15,001 - $50,000 |
| 2022-01-28 | Virginia Ann Foxx | Sale (Full) | $50,001 - $100,000 |
| 2021-11-08 | Virginia Ann Foxx | Purchase | $1,001 - $15,000 |
| 2021-08-09 | Virginia Ann Foxx | Purchase | $1,001 - $15,000 |
| 2021-08-06 | Virginia Ann Foxx | Purchase | $1,001 - $15,000 |
| 2021-05-27 | Virginia Ann Foxx | Purchase | $15,001 - $50,000 |
| 2021-05-12 | Virginia Ann Foxx | Purchase | $15,001 - $50,000 |
| 2021-04-19 | Virginia Ann Foxx | Purchase | $50,001 - $100,000 |
| 2020-03-31 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2019-03-25 | Van Taylor | Sale (Full) | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-06 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
NHI presents a moderate opportunity driven by a credible congressional trade signal ahead of a confirmed $107.7M SHOP investment, supported by positive senior housing REIT momentum.
The first sentence of the analysis written for NHI on 2026-10-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Neutral signal
Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. No open-market purchase or sale value stored
- Congress Supports a bullish reading. 2 purchase disclosures year to date
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 2.48 · operating margin 51%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 36.7% | 96.7% | 96.4% | 96.5% | 96.1% | |
| Ebit Margin | 52.3% | 57.5% | 59.4% | 38.8% | 53.6% | |
| Ebitda Margin | 74.5% | 78.8% | 81.3% | 64.2% | 80.7% | |
| Operating Profit Margin | 51.5% | 54.9% | 55.9% | 47.7% | 62.0% | |
| Pretax Profit Margin | 37.2% | 40.8% | 42.0% | 23.5% | 37.5% | |
| Continuous Operations Profit Margin | 37.2% | 40.8% | 42.0% | 23.5% | 37.5% | |
| Net Profit Margin | 37.6% | 41.2% | 42.4% | 23.9% | 37.4% | |
| Bottom Line Profit Margin | 37.6% | 41.1% | 42.4% | 23.9% | 37.4% | |
| Current Ratio | 2.482 | 0.958 | 1.157 | 3.419 | 7.336 | |
| Quick Ratio | 2.482 | 0.958 | 1.157 | 3.419 | 7.336 | |
| Solvency Ratio | 0.180 | 0.170 | 0.169 | 0.113 | 0.146 | |
| Cash Ratio | 0.157 | 0.059 | 0.069 | 0.172 | 0.533 | |
| Price To Earnings Ratio | 25.205 | 22.070 | 17.843 | 100.423 | 42.257 | |
| Price To Earnings Growth Ratio | -7.195 | 69.079 | 0.036 | -1.626 | -0.767 | |
| Forward Price To Earnings Growth Ratio | -7.195 | 69.079 | 0.036 | -1.626 | -0.767 | |
| Price To Earnings Diluted Ratio | 25.288 | 22.141 | 17.843 | 102.392 | 42.257 | |
| Price To Earnings Diluted Growth Ratio | -7.196 | 0.000 | 0.035 | -1.638 | -0.767 | |
| Price To Book Ratio | 2.353 | 2.224 | 1.933 | 1.841 | 1.743 | |
| Price To Sales Ratio | 9.457 | 9.065 | 7.577 | 8.405 | 8.795 | |
| Price To Free Cash Flow Ratio | 16.253 | 15.789 | 13.410 | 12.939 | 12.463 | |
| Price To Operating Cash Flow Ratio | 14.902 | 14.596 | 13.138 | 12.615 | 12.459 | |
| Debt To Assets Ratio | 0.416 | 0.438 | 0.456 | 0.458 | 0.441 | |
| Debt To Equity Ratio | 0.765 | 0.839 | 0.905 | 0.903 | 0.831 | |
| Debt To Capital Ratio | 0.433 | 0.456 | 0.475 | 0.475 | 0.454 | |
| Long Term Debt To Capital Ratio | 0.406 | 0.374 | 0.415 | 0.465 | 0.452 | |
| Financial Leverage Ratio | 1.838 | 1.913 | 1.985 | 1.974 | 1.884 | |
| Working Capital Turnover Ratio | 4.512 | 20.092 | 1.988 | 0.777 | 1.148 | |
| Operating Cash Flow Ratio | 1.922 | 0.502 | 0.569 | 1.655 | 3.005 | |
| Operating Cash Flow Sales Ratio | 0.635 | 0.621 | 0.577 | 0.666 | 0.706 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.917 | 0.924 | 0.980 | 0.975 | 1.000 | |
| Debt Service Coverage Ratio | 1.546 | 0.682 | 0.865 | 2.118 | 5.007 | |
| Interest Coverage Ratio | 3.396 | 3.276 | 3.221 | 3.128 | 3.850 | |
| Short Term Operating Cash Flow Coverage Ratio | 1.922 | 0.629 | 0.753 | 4.413 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.206 | 0.182 | 0.163 | 0.162 | 0.168 | |
| Capital Expenditure Coverage Ratio | 12.032 | 13.231 | 49.279 | 40.039 | 3,294.672 | |
| Dividend Paid And Capex Coverage Ratio | 1.267 | 1.209 | 1.153 | 1.114 | 1.152 | |
| Dividend Payout Ratio | 1.194 | 1.134 | 1.152 | 2.436 | 1.636 | |
| Enterprise Value Multiple | 16.752 | 15.749 | 13.607 | 19.394 | 15.944 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 36.7% | ▼-60.0% | ▼-47.8% |
| Ebit Margin | 52.3% | ▼-5.1% | ▲0.0% |
| Ebitda Margin | 74.5% | ▼-4.3% | ▼-1.4% |
| Operating Profit Margin | 51.5% | ▼-3.4% | ▼-2.9% |
| Pretax Profit Margin | 37.2% | ▼-3.6% | ▲1.0% |
| Continuous Operations Profit Margin | 37.2% | ▼-3.6% | ▲1.0% |
| Net Profit Margin | 37.6% | ▼-3.6% | ▲1.1% |
| Bottom Line Profit Margin | 37.6% | ▼-3.6% | ▲1.1% |
| Current Ratio | 2.482 | ▲1.524 | ▼-0.589 |
| Quick Ratio | 2.482 | ▲1.524 | ▼-0.589 |
| Solvency Ratio | 0.180 | ▲0.009 | ▲0.024 |
| Cash Ratio | 0.157 | ▲0.098 | ▼-0.041 |
| Price To Earnings Ratio | 25.205 | ▲3.135 | ▼-16.355 |
| Price To Earnings Growth Ratio | -7.195 | ▼-76.274 | ▼-19.100 |
| Forward Price To Earnings Growth Ratio | -7.195 | ▼-76.274 | ▼-19.100 |
| Price To Earnings Diluted Ratio | 25.288 | ▲3.147 | ▼-16.696 |
| Price To Earnings Diluted Growth Ratio | -7.196 | ▼-7.196 | ▼-5.282 |
| Price To Book Ratio | 2.353 | ▲0.129 | ▲0.334 |
| Price To Sales Ratio | 9.457 | ▲0.392 | ▲0.797 |
| Price To Free Cash Flow Ratio | 16.253 | ▲0.463 | ▲2.082 |
| Price To Operating Cash Flow Ratio | 14.902 | ▲0.306 | ▲1.360 |
| Debt To Assets Ratio | 0.416 | ▼-0.022 | ▼-0.026 |
| Debt To Equity Ratio | 0.765 | ▼-0.074 | ▼-0.084 |
| Debt To Capital Ratio | 0.433 | ▼-0.023 | ▼-0.025 |
| Long Term Debt To Capital Ratio | 0.406 | ▲0.032 | ▼-0.017 |
| Financial Leverage Ratio | 1.838 | ▼-0.075 | ▼-0.081 |
| Working Capital Turnover Ratio | 4.512 | ▼-15.579 | ▼-1.191 |
| Operating Cash Flow Ratio | 1.922 | ▲1.419 | ▲0.391 |
| Operating Cash Flow Sales Ratio | 0.635 | ▲0.014 | ▼-0.006 |
| Free Cash Flow Operating Cash Flow Ratio | 0.917 | ▼-0.007 | ▼-0.042 |
| Debt Service Coverage Ratio | 1.546 | ▲0.864 | ▼-0.497 |
| Interest Coverage Ratio | 3.396 | ▲0.120 | ▲0.022 |
| Short Term Operating Cash Flow Coverage Ratio | 1.922 | ▲1.293 | ▲0.379 |
| Operating Cash Flow Coverage Ratio | 0.206 | ▲0.025 | ▲0.030 |
| Capital Expenditure Coverage Ratio | 12.032 | ▼-1.199 | ▼-669.819 |
| Dividend Paid And Capex Coverage Ratio | 1.267 | ▲0.058 | ▲0.088 |
| Dividend Payout Ratio | 1.194 | ▲0.059 | ▼-0.317 |
| Enterprise Value Multiple | 16.752 | ▲1.003 | ▲0.463 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.58B | $3.04B | $2.42B | $2.34B | $2.63B | |
| Enterprise value | $4.72B | $4.16B | $3.54B | $3.47B | $3.84B | |
| EV / Sales | 12.48x | 12.41x | 11.06x | 12.46x | 12.86x | |
| EV / Op. cash flow | 19.66x | 19.98x | 19.17x | 18.70x | 18.22x | |
| EV / Free cash flow | 21.45x | 21.62x | 19.57x | 19.18x | 18.22x | |
| EV / EBITDA | 16.75x | 15.75x | 13.61x | 19.39x | 15.94x | |
| Net debt / EBITDA | 4.06x | 4.25x | 4.28x | 6.31x | 5.04x | |
| Current ratio | 2.48x | 0.96x | 1.16x | 3.42x | 7.34x | |
| Income quality | 1.69x | 1.51x | 1.37x | 2.83x | 1.88x | |
| Graham number | $47 | $47 | $45 | $31 | $43 | |
| Graham net-net | -$22 | -$21 | -$22 | -$21 | -$21 | |
| Tax burden | 101.0% | 101.0% | 100.9% | 101.5% | 99.8% | |
| Interest burden | 71.0% | 70.9% | 70.8% | 60.6% | 70.0% | |
| Working capital | $185.2M | -$17.4M | $50.8M | $271.0M | $444.6M | |
| Invested capital | $185.2M | -$17.4M | $50.8M | $271.0M | $444.6M | |
| Return on assets | 5.1% | 5.3% | 5.5% | 2.6% | 3.9% | |
| Operating ROA | 7.2% | 7.2% | 7.2% | 5.0% | 6.2% | |
| Return on tangible assets | 5.1% | 5.3% | 5.5% | 2.6% | 3.9% | |
| Return on equity | 9.3% | 10.1% | 10.8% | 5.2% | 7.4% | |
| Return on invested capital | 7.0% | 7.3% | 7.4% | 5.4% | 6.7% | |
| Return on capital employed | 7.3% | 8.4% | 8.3% | 5.5% | 6.7% | |
| Earnings yield | 4.0% | 4.5% | 5.6% | 2.8% | 4.3% | |
| Free cash flow yield | 6.2% | 6.3% | 7.5% | 7.7% | 8.0% | |
| Capex / Op. cash flow | 8.3% | 7.6% | 2.0% | 2.5% | 0.0% | |
| Capex / Depreciation | 23.8% | 21.2% | 5.3% | 6.5% | 0.1% | |
| Capex / Sales | 5.3% | 4.7% | 1.2% | 1.7% | 0.0% | |
| SG&A / Sales | 0.0% | 6.5% | 6.2% | 9.1% | 6.5% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.0% | 1.4% | 3.1% | 2.8% | |
| Intangibles / Total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 280d | 403d | 394d | 417d | 500d | |
| Days payables outstanding | 0d | 1234d | 1088d | 966d | 727d | |
| Operating cycle | 280d | 403d | 394d | 417d | 500d | |
| Cash conversion cycle | 280d | -831d | -693d | -549d | -227d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+17.8%EV / Sales ▲+0.5%EV / EBITDA ▲+6.4%EV / Op. cash flow ▼-0.320Earnings yield ▼-0.006Graham number ▲+0.089
Profitability
Return on equity ▼-0.008Return on assets ▼-0.002Return on invested capital ▼-0.003Return on capital employed ▼-0.011Operating ROA -0.000Income quality ▲+0.181Tax burden -0.000
Efficiency
Days sales outstanding ▼-123.149Days payables outstanding ▼-1234.331Operating cycle ▼-123.149Cash conversion cycle ▲+1111.182Capex / Sales ▲+0.006R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+1.524Net debt / EBITDA ▼-0.189Working capital ▲+202665000.000Invested capital ▲+202665000.000Intangibles / Total assets n/a
Change over 5 years
Valuation
Market cap ▲+36.3%EV / Sales ▼-3.0%EV / EBITDA ▲+5.1%EV / Op. cash flow ▲+1.447Earnings yield ▼-0.003Graham number ▲+4.473
Profitability
Return on equity ▲+0.019Return on assets ▲+0.011Return on invested capital ▲+0.003Return on capital employed ▲+0.006Operating ROA ▲+0.010Income quality ▼-0.194Tax burden ▲+0.012
Efficiency
Days sales outstanding ▼-219.429Days payables outstanding ▼-727.021Operating cycle ▼-219.429Cash conversion cycle ▲+507.591Capex / Sales ▲+0.053R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-4.854Net debt / EBITDA ▼-0.982Working capital ▼-259394000.000Invested capital ▼-259394000.000Intangibles / Total assets n/a
Employee count
Peer market caps
Recent news
- 2026-10-03 National Health Investors, Inc. (NYSE:NHI) Stock Rated “Moderate Buy” by Wall Street Brokerages Shares of National Health Investors, Inc. (NYSE: NHI - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine analysts that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average
- 2026-10-01 NHI Announces $107.7 Million SHOP Investment MURFREESBORO, Tenn., Oct. 1, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE:NHI) announced today that it invested $107.7 million, including transaction costs, for the acquisition of six properties with 443 units in Kentucky, Michigan and Tennessee.
- 2026-09-30 The Senior Housing Boom Is Here. These 5 REITs Are Paying Investors to Ride It Five senior housing REITs all raised their dividends in 2026, but the cash flow cushions behind those payouts vary wildly, and at least one carries a tenant whose survival is already in question.
- 2026-09-28 National Health Investors, Inc. (NYSE:NHI) Shareholders to Get $0.92 Quarterly Dividend National Health Investors, Inc. (NYSE: NHI - Get Free Report) announced a quarterly dividend on Friday, August 7th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.92 per share by the real estate investment trust on Friday, November 6th. This represents a $3.68 annualized dividend and a dividend yield of 5.5%.
- 2026-09-24 BXP vs. NHI: Which Stock Is the Better Value Option? Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of Boston Properties (BXP) and National Health Investors (NHI). But which of these two stocks is more attractive to value investors?
- 2026-09-21 Very Bad News For REITs, But I Am Buying The Dip The Fed''s first hike in years has hit REITs hard. Higher rates may actually create a silver lining. Some well-capitalized REITs could benefit from this selloff.
- 2026-09-14 NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline MURFREESBORO, Tenn., Sept. 14, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced today that management will participate in investor meetings at the BofA Securities 2026 Global Real Estate Conference on September 15, 2026.
- 2026-09-10 3 More Buys In Senior Housing REITs Senior Housing REITs are outperforming major indices, driven by a persistent supply-demand imbalance and favorable demographic trends. This article previews 3 Senior Housing REITs that offer high yields and strong balance sheets while trading at attractive FFO multiples. All three REITs present robust internal and external growth potential as occupancy rates climb, with yields well above Treasury rates.
- 2026-09-03 Primary Health Properties (OTCMKTS:PHPRF) versus National Health Investors (NYSE:NHI) Head-To-Head Review National Health Investors (NYSE: NHI - Get Free Report) and Primary Health Properties (OTCMKTS:PHPRF - Get Free Report) are both real estate companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Valuation and Earnings This table
- 2026-09-01 Canada Pension Plan Investment Board Invests $1.23 Million in National Health Investors, Inc. $NHI Canada Pension Plan Investment Board bought a new position in shares of National Health Investors, Inc. (NYSE: NHI) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 16,100 shares of the real estate investment trust''s stock, valued at